Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
Date:2/24/2009

hich may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Disclosure Notice

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. Forward looking statements in this press release include our financial guidance for 2009, and statements regarding our clinical development programs, the effectiveness of our Vancocin and Cinryze sales efforts, our estimates of future tax rates, or our ability to execute a successful launch of Cinryze, our ability to conduct future studies with maribavir, and the timing and potential outcomes of the review of our regulatory submission related to an acute treatment indication for Cinryze.

Our 2009 revenue guidance is based upon our plans to remain vigorous in our opposition to any bioequivalence approach considered for use in approving generic formulations of Vancocin that does not require rigorous scientific methods to demonstrate safety and efficacy consistent with good medicine and science. There can be no assurance that the FDA will agree with the positions stated in our Vancocin related submissions or that our efforts to oppose the FDA's December 2008 bioequivalence guidance for Vancocin will be successful. We cannot predict the timeframe in which the FDA will make a decision regarding either our citizen petition for Vancocin or the approval of generic versions of Vancocin. If we are unable to change the recommendation set forth by the FDA in December 2008, the threat of generic competition will be high. The entry of competing generic products will significantly affect our sales of Vancoci
'/>"/>

SOURCE ViroPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma to Present at Three October Healthcare Conferences
5. ViroPharma to Present at Three September Healthcare Conferences
6. ViroPharma To Acquire Lev Pharmaceuticals
7. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
8. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
9. ViroPharma to Present at Two Upcoming Healthcare Conferences
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... (Nasdaq: NEOG ) announced today that net ... year, which ended Aug. 31, was $8,883,000 — a ... the first quarter of last year. Adjusted for a ... share in the current quarter were $0.24, compared to ... increased 15% to $67,599,000, from the previous year,s first ...
(Date:9/22/2014)... , Sept. 22, 2014  WIRB-Copernicus Group ... ethical review services for clinical research, announced today ... (WIRB) has been reaccredited by the Association for ... which endeavors to improve safeguards for clinical research ... Donald A. Deieso , Ph.D., commented, "It is ...
(Date:9/22/2014)... METTLER TOLEDO is pleased to ... device CNS110 ScanTape™ . Replacing a traditional ... greater ease and accuracy for transport and logistics ... enhance productivity—an important benefit for load planning and ... profits. , Usable at any point in ...
(Date:9/22/2014)... Incorporated (SPEX) -- an intellectual property development company committed to ... the United States Patent & Trademark Office (USPTO) issued a ... that is part of a standard essential family of patents. ... , Application number: US 13/728,867 , Publication date: Sep ... The listed inventors of the new patent, entitled ...
Breaking Biology Technology:Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2ScanTape™ Handheld Dimensioner Increases Processing Volume 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3
... gave about $400,000 worth of software to Lad ... and their families. Rob Busch, enterprise sales manager for ... the non-profit's Synergy School in Milwaukee for the formal ... upgrade Lad Lakes network and software infrastructure, including the ...
... NimbleGen Systems Inc. closed its latest, $8.2 ... to $50 million, the company said. , ,The company makes ... have thousands of individual genetic samples on them arranged in ... of DNA and do comparisons. , , Cargill Ventures ...
... in the next ten years, according to a proposal that ... the Senate for a vote this month. State Senator Joe ... Wisconsin that would be regulated similarly to airports. , ,Leibhams ... regulate private space travel in the area, receive any potential ...
Cached Biology Technology:Space port could open in Sheboygan in next 10 years 2Space port could open in Sheboygan in next 10 years 3
(Date:9/22/2014)... vanished from tropical islands because of human impact, ... fossils can be used to restore lost biodiversity. ... found in fossil bones, which contain evidence for ... study available online and in the September issue ... island ecosystems provide vital clues for saving endangered ...
(Date:9/22/2014)... crop by-products such as straw could be made quicker ... the UK and France. , Researchers funded by ... discovered variant straw plants whose cell walls are more ... not significantly smaller or weaker than regular plants. ... food security as biofuels from non-food crops become easier ...
(Date:9/22/2014)... Brain & Behavior Research Foundation today ... Investigator Grants valued at more than $12.7 ... promising young scientists. Recipients of the $30,000+/year, ... seek to identify causes, improve treatments and ... affect one in four people, including anxiety, ...
Breaking Biology News(10 mins):Answer to restoring lost island biodiversity found in fossils 2Plant variants point the way to improved biofuel production 2Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2
... from UC San Diego are collaborating with scientists ... to map patterns of biodiversity and land use ... combined with climate models, will project how climate ... policy for setting aside conservation easements. Wildlife, ...
... the biggest challenges facing humanity is to halt the destruction ... task that must be urgently addressed and in which we ... is our duty to do all we can for the ... researchers Harold Mooney and Peter Raven, regarded as the architects ...
... In a recent paper published in Nature Geoscience (*), ... Centre for Geosciences, Potsdam and her Danish colleague Nils ... that motions in the fluid in the Earths core ... effects the magnetic field of our Planet. ...
Cached Biology News:Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa 2Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa 3BBVA Foundation Awards for Biodiversity Conservation 2BBVA Foundation Awards for Biodiversity Conservation 3BBVA Foundation Awards for Biodiversity Conservation 4
... These precision 5mm diameter, 7 inch long ... glass for compatibility with ground joints, valves, and ... NMR spectrometers running from 300 to 500MHz. They ... an I.D. of 4.20 + 0.013-0.000mm. These NMR ...
Preparation TW--Compatibility: Push-on end cap seals suitable up to 70 C only -Hybridization Tube for Model HB-1D -Comp Dim: 200 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-12...
... The VSN-5 Nutating Mixer is a combination ... produces a three dimensional action while providing ... high quality unit can be used for ... resuspension of specimens, tissue culture, immunoblots, staining/destaining, ...
... TProfessional Thermocycler combines top performance with exquisite ... high speed and unparalleled temperature uniformity. The ... programming in a spreadsheet or alternatively in ... Lid opens on the push of a ...
Biology Products: